Corteva, Inc. (CTVA)

FairStock Score: 39/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I approach Corteva as a cyclical agricultural-inputs business, not as a wide-moat compounder. The filed numbers show why: in fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $6.4B, net income $1.2B, and diluted EPS $1.73, but in fiscal Q3 2025, the quarter ended 2025-09-30, revenue was $2.6B and net income was a $320M loss with diluted EPS of -$0.47. For the full year, FY2025 revenue was $17.4B, net income $1.1B, and diluted EPS $1.60, versus FY2024 net income of $907M and diluted EPS of $1.30, so earnings have improved but remain sensitive to the farm cycle. Financial health is mixed: debt-to-equity is low at 0.19 and the Piotroski F-Score is 6/9, yet FairStock's Altman Z-Score is only 0.65, and returns on equity and capital are modest at 4.26% and 4.55%. At the 2026-10-26 close of $11.95, FairStock calculates a P/E of 7.24, P/B of 0.32, EV/EBITDA of 3.08, and FCF yield of 25.7%; the Graham Number is $36.74, a 66.11% margin of safety. That is statistically cheap, and the $2.0B trailing free cash flow is substantial against an $8.0B market cap. But cheapness on cyclical or distressed-looking numbers deserves caution. I would want evidence that cash flow and returns are durable before treating the discount as a margin of safety rather than a warning.

In plain English: Corteva sells seeds and crop-protection products to farmers. The business looks mixed: it has strong cash generation and low debt, but profits swing sharply by quarter and returns are low. At $11.95 on 2026-10-26, the price looks cheap compared with its profits and cash generation, though the market may be worried about the risks.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-26 close · note generated 2026-10-28 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer